ArticleScientific reports2025
Dynamics and genetic variation of dengue virus serotypes circulating during the 2022 outbreak in Karachi.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Designing potent and immunogenic epitope based peptide vaccine against all serotypes of DENV via structural, physico-chemical and immunoinformatics-based approaches.Scientific reports · 2026Article
- Spatiotemporal patterns and forecasted trends of dengue in Saudi Arabia: a national surveillance study, 2012-2024.BMC infectious diseases · 2026Article
- Molecular Characterization of DENV-1 Isolates From Pakistan Reveals Immunogenic Variability and Antiviral Potential of Phytochemicals Targeting the CprM Region.Journal of tropical medicine · 2026Article
- The Impacts of Dengue Virus Infection on Mitochondrial Functions and Dynamics.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue virus (DENV) poses a critical health threat causing millions of cases every year. The absence of proof-reading activity of the RNA-dependent RNA polymerases (RdRp) leads to significant mutations in its genome. This may result in genetic diversity among the genotypes which contribute to severe complications during the infection. Targeting these mutations may help to understand the viral transmission and identify a potential treatment. An aggregate of 152 dengue positive serum samples were collected from different tertiary care hospitals in Karachi. RNA isolation, cDNA synthesis as well as amplification of the C-prM region was performed, followed by the Sanger sequencing. The resultant sequences of each serotype were aligned with their respective genome sequences and phylogenetic trees based on genotypes were constructed using Maximum Likelihood (ML) method with 1000 bootstraps replicates. The sequences were then converted to the amino acid sequence and genetic variations in comparison to the reference genomes were evaluated. The results showed that there was a higher number of positive cases in males (58%) than in females (42%). The most affected age group was 21-30. The study suggested that the dominant serotype in the population of Karachi was DENV-1 (78.33%), followed by DENV- 2 (15%) and DENV-3 (6.66%). Overall, the acquired data provide the information about genetic variation in the C-prM region of dengue virus in Karachi, Pakistan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.